GLP1 + Cagrilintide

Description

This dual-peptide formulation combines GLP-1 (Glucagon-Like Peptide-1) with Cagrilintide, designed for advanced research into metabolic regulation, appetite signaling, and energy homeostasis. GLP-1 is an incretin hormone analog studied for its role in enhancing insulin secretion, slowing gastric emptying, and modulating central appetite pathways. Cagrilintide is a synthetic analog of amylin, a hormone co-secreted with insulin, and is studied for its impact on satiety and food intake through the area postrema and hypothalamic receptors. Together, these peptides are used in in vitro models exploring synergistic effects on neuroendocrine signaling, glucose balance, and body weight regulation.